1-20 of 21
Keywords: Synergy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (2020) 64 (5-6): 233–237.
Published Online: 12 May 2020
...Thomas J. Dilworth; Daniel Sanchez; Beverly Anderson; Haedi DeAngelis; Renée-Claude Mercier Previous studies have demonstrated synergy between piperacillin (PIP)-tazobactam (TAZ) (TZP) and vancomycin (VAN) against methicillin-resistant Staphylococcus aureus (MRSA). However, it is unknown whether...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (2014) 59 (6): 447–452.
Published Online: 14 August 2014
..., instructions or products referred to in the content or advertisements. Anthraquinone Diacetyl rhein Antibacterial activity Staphylococcus aureus Synergy Staphylococcus aureus continues to cause antibiotic-resistant health care- and community-associated infections worldwide [ 1,2 ] due...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (2012) 57 (5): 426–433.
Published Online: 26 November 2011
... twice onto a blood agar plate (with 5% defibrinated sheep blood; bioMérieux SA, Marcy-l’Etoile, France) before use. E. faecalis ATCC 29212 was included as a quality control strain. Mueller-Hinton II agar plates (bioMérieux SA) were used to evaluate the MICs by the E-test (bioMérieux SA) synergy...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1995) 41 (3): 165–171.
Published Online: 11 September 2009
... resistance to gentamicin and different MICs for penicillin were tested for antibiotic synergy using time-killing curves. When penicillin concentrations equal to or higher than the MICs were used, synergism was established, even when highly penicillin-resistant strains (MIC > 200 mg/l) were tested...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1995) 41 (5): 330–333.
Published Online: 11 September 2009
... for the pulmonary deterioration in these patients. Tobramycin has variable inhibitory effects on these organisms, but in many isolates this inhibition is increased in vitro by exposure to the diuretic, amiloride. Aerosolized amiloride has been shown to be of clinical benefit in CF. The basis for this synergy...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1997) 43 (2): 100–107.
Published Online: 11 September 2009
... agents with amine groups. To examine the relationship of substituted amine drug structure and synergy potential with tobramycin, the in vitro activity of 45 non-antibiotic substituted amine and related compounds in the presence and absence of tobramycin was studied. Very few agents had intrinsic...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1997) 43 (2): 108–117.
Published Online: 11 September 2009
...Karl J. Madaras-Kelly; Julia Moody; Alison Larsson; Laurie Baeker Hovde; John C. Rotschafer The purposes of this study were to investigate the potential for synergy between ceftazidime, tobramycin, and ofloxacin against two clinical isolates (PSA 9258, and PSA 9263) of Pseudomonas aeruginosa...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1992) 38 (3): 174–178.
Published Online: 10 September 2009
..., instructions or products referred to in the content or advertisements. 10 9 2009 Saperconazole Candida species Fluconazole Amphotericin B Synergy KP. Fu D. Isaacson B. Foleno J. LoCoco Microbiology Research, The R.W. Johnson Pharmaceutical Research Institute, Raritan, N.J., USA M...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1985) 31 (5): 351–361.
Published Online: 09 September 2009
... to in the content or advertisements. Endocarditis Pseudomonas aeruginosa Synergy Aminoglycosides Cephalosporins Experimental Chemotherapy Chemotherapy 31: 351-361(1985) (g) 1985 S. Karger, Basel 0009-3157/85/0315-0351 S2.75/0 Amikacin + Ceftazidime Therapy of Experimental Right-Sided Pseudomonas...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1985) 31 (5): 336–345.
Published Online: 09 September 2009
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Synergy Cefotaxime...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1985) 31 (2): 102–111.
Published Online: 09 September 2009
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Latamoxef Synergy Ticarcillin Aminoglycoside Chemotherapy 31: 102-111(1985) © 1985 S. Karger AG. Basel 0009-3157/85/0312-0102 $ 2.75/0 Latamoxef in Combination...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1978) 24 (5): 283–289.
Published Online: 08 September 2009
...Russell A. Klein; Richard D. Meyer The predictability of synergy with strains of Pseudomonas aeruginosa highly resistant to gentamicin in combination with carbenicillin has been controversial. 30 clinical isolates of P. aeruginosa resistant to gentamicin and/or carbenicillin were tested...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1979) 25 (1): 30–39.
Published Online: 08 September 2009
... to the particular bacterial species under test and synergy was observed only against bacteria with chromosomally-mediated β-lactamases and not against bacteria with R-factor-mediated β -lactamases. In general, amoxycillin+flucloxacillin demonstrated activity against experimental mouse infections in good agreement...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1979) 25 (5): 296–302.
Published Online: 08 September 2009
...Daphne Grey; J.M.T. Hamilton-Miller; W. Brumfitt 42 strains of gram-negative bacteria, isolated from clinical material, resistant to trimethoprim (TM), sulphamethoxazole (SMZ) or both, have been tested for synergistic sensitivity to TM + SMZ. The combination showed no synergy against strains...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1984) 30 (3): 165–169.
Published Online: 08 September 2009
... resistant isolates. 8 9 2009 Cephalosporins Penicillins Aminoglycosides Pseudomonas Resistance induction Synergy © 1984 S. Karger AG, Basel 1984 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages...
Journal Articles
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1978) 24 (3): 166–171.
Published Online: 08 September 2009
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Erythromycin Chloramphenicol Polymyxin Tetracycline Neomycin Pseudomonas Ascorbic acid Synergy Vitamin C...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1977) 23 (Suppl. 1): 86–92.
Published Online: 05 August 2009
..., instructions or products referred to in the content or advertisements. Fosfomycin Interactions Isobologram Synergy ...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (1977) 23 (6): 452–457.
Published Online: 05 August 2009
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Caffeine Theophylline Protein synthesis PeniciUinase Synergy Staphylococcus Chemotherapy 23: 452-457 (1977) Action...
Journal Articles
Subject Area:
Further Areas , Oncology , Pharmacology
Chemotherapy (2002) 48 (4): 182–188.
Published Online: 13 September 2002
... Pharmacodynamics Antibiotics Cytostatic drugs Synergy Biofilm Microbiology Chemotherapy 2002;48:182 188 Postantibiotic Effect of Meropenem and Ciprofloxacin in the Presence of 5-Fluorouracil A. Nyhléna B. Ljungberga I. Nilsson-Ehlea I. Odenholtb Departments of Infectious Diseases, University Hospitals...